PDCD1 and colorectal carcinoma: Research in a murine model of mismatch-repair-proficient (pMMR) CRC confirmed the inverse association between the therapeutic efficacy of PD-1 inhibitors and serum LDH levels (263, 264), with patients experiencing enhanced effectiveness of PD-1 blockade when combined with LDHA inhibition (178).